Published in Cold Spring Harb Symp Quant Biol on January 01, 1962
Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med (1969) 6.03
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol (1984) 5.57
Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68
Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci U S A (1991) 2.41
Histocompatibility-linked genetic control of disease susceptibility. Murine lymphocytic choriomeningitis virus infection. J Exp Med (1973) 2.39
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37
Immunopathology of lymphocytic choriomeningitis viurs infection of newborn mice. Antithymocyte serum effects on glomerulonephritis and wasting disease. J Exp Med (1968) 2.31
Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc Natl Acad Sci U S A (1997) 2.23
Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med (1992) 2.22
A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci U S A (1997) 2.20
IMMUNOFLUORESCENT STUDIES OF THE HISTOPATHOGENESIS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTION. J Exp Med (1964) 2.19
Biochemical challenge of microbial pathogenicity. Bacteriol Rev (1968) 2.14
Viral hepatitis and tests for the Australia (hepatitis-associated) antigen and antibody. Bull World Health Organ (1970) 2.05
Antiviral action of immune lymphocytes in mice infected with lymphocytic choriomeningitis virus. Infect Immun (1972) 1.93
Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J Exp Med (1997) 1.93
Arenoviruses in Vero cells: ultrastructural studies. J Virol (1970) 1.91
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc Natl Acad Sci U S A (1999) 1.49
Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression. J Exp Med (1977) 1.49
Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc Natl Acad Sci U S A (1977) 1.49
Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus. J Exp Med (1998) 1.44
Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc Natl Acad Sci U S A (2003) 1.41
Australia antigen and autoantibodies in chronic hepatitis. Br Med J (1970) 1.40
Kinetics of protective antibodies are determined by the viral surface antigen. J Clin Invest (2004) 1.39
Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). Am J Pathol (1983) 1.37
Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. Proc Natl Acad Sci U S A (1999) 1.35
Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells. J Exp Med (1988) 1.31
Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A (1978) 1.30
Variation between strains of hamsters in the lethality of Pichinde virus infections. Infect Immun (1977) 1.28
Effects of promyelocytic leukemia protein on virus-host balance. J Virol (2002) 1.28
HEBERDEN ORATION, 1964. SOME IMMUNOLOGIC ASPECTS OF THE CONNECTIVE TISSUE DISEASES. Ann Rheum Dis (1965) 1.25
Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice. J Virol (1998) 1.21
Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon. J Exp Med (1980) 1.19
Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice. Immunology (1985) 1.18
Dual role of the immune response in street rabiesvirus infection of mice. Infect Immun (1982) 1.16
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine (2007) 1.13
Role of lymphocytic choriomeningitis virus (LCMV) in understanding viral immunology: past, present and future. Viruses (2012) 1.12
Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci U S A (1994) 1.12
Review: antigens and viruses in acute hepatitis. Clin Exp Immunol (1970) 1.09
Persistent infection of the mouse with the virus of lymphocytic choriomeningitis. J Clin Pathol Suppl (R Coll Pathol) (1972) 1.04
Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells. J Virol (1997) 1.02
Effect of antilymphocyte serium on tacaribe virus infection in infant mice. Infect Immun (1971) 1.01
RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2005) 0.97
Major histocompatibility complex-linked susceptibility or resistance to disease caused by a noncytopathic virus varies with the disease parameter evaluated. J Exp Med (1989) 0.95
Low-pathogenicity variant of lymphocytic choriomeningitis virus. Infect Immun (1973) 0.94
IN VIVO ANTIVIRAL ACTIVITY OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA. Appl Microbiol (1965) 0.94
Experimental viral hepatitis in the dog: production of persistent disease in partially immune animals. J Clin Invest (1967) 0.93
Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology. J Virol (1992) 0.93
The contamination of laboratory animals with lymphocytic choriomeningitis virus. Am J Pathol (1971) 0.92
In vitro studies on the antiviral activity of 1, 3-bis(2-chloroethyl)-1-nitrosourea. Appl Microbiol (1966) 0.91
Lymphocytic choriomeningitis virus infection in fetal, newborn, and young adult Syrian hamsters (Mesocricetus auratus). Infect Immun (1976) 0.90
Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats: protective effect of immunosuppression with anti-lymphoid serum. Infect Immun (1974) 0.89
Congenital infections with reovirus. J Exp Med (1966) 0.89
Laboratory diagnosis of lymphocytic choriomeningitis. Bull World Health Organ (1975) 0.88
Homologous disease in the adult rat, a model for autoimmune disease. II. Findings in the joints, heart, and other tissues. J Exp Med (1965) 0.86
Immune complex diseases. I. Pathological changes in the kidneys of BALB-c mice neonatally infected with Moloney leukaemogenic and murine sarcoma viruses. Clin Exp Immunol (1971) 0.85
Regulation of immune response and inflammatory reactions against viral infection by VCAM-1. J Virol (2008) 0.82
[Wasting disease produced in hamsters after the inoculation of a bovine leukemic material]. Can J Comp Med (1968) 0.80
[Electron microscopy demonstration of "virus-like" inclusion bodies in myoepithelial sialadenitis within the scope of "Sjögren's" syndrome]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1972) 0.78
Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. III. In vivo protective activity of effector cells generated in vitro. Immunology (1978) 0.77
Current views on the pathogenesis and etiology of rheumatoid arthritis. Can Med Assoc J (1969) 0.75
Electrocardiographic pattern in intracranial hemorrhage. Can Med Assoc J (1969) 0.75
Malignant lymphomas in hamsters following a wasting disease produced with bovine leukemic extract--a preliminary report. Can J Comp Med (1969) 0.75
The nature and significance of the Australia antigen. Proc R Soc Med (1971) 0.75
Experimental animals and in vitro systems in the study of lymphocytic choriomeningitis virus. Bull World Health Organ (1977) 0.75
Profile of Michael B. A. Oldstone. Interview by Nicholette Zeliadt. Proc Natl Acad Sci U S A (2013) 0.75
GLOMERULONEPHRITIS AND LATE ONSET DISEASE OF MICE FOLLOWING NEONATAL VIRUS INFECTION. Nature (1964) 1.88
Studies of lymphocytic choriomeningitis in mice. I. The relationship between age at inoculation and outcome of infection. J Immunol (1961) 1.67
The effects of pretreatment with x-rays on the pathogenesis of lymphocytic choriomeningitis in mice. I. Host survival, virus multiplication and leukocytosis. J Immunol (1961) 1.65
THE PATHOGENESIS OF LYMPHOCYTIC CHORIOMENINGITIS IN MICE: THE EFFECTS OF DIFFERENT INOCULATION ROUTES AND THE FOOTPAD RESPONSE. J Immunol (1963) 1.39
The foot pad reaction of mice to lymphocytic choriomeningitis virus. Virology (1962) 1.34
Studies of lymphocytic choriomeningitis in mice. II. A comparison of the immune status of newborn and adult mice surviving inoculation. J Immunol (1961) 1.17
INCREASED SUSCEPTIBILITY OF MICE TO LYMPHOCYTIC CHORIOMENINGITIS VIRUS AFTER PERIPHERAL INOCULATION. Virology (1963) 1.14
SOVIET SEARCH FOR VIRUSES THAT CAUSE CHRONIC NEUROLOGIC DISEASES IN THE U.S.S.R. Science (1965) 1.01
Effect of Eperythrozoon coccoides upon lymphocytic choriomeningitis in mice. J Immunol (1961) 0.98
The effects of pretreatment with x-rays on the pathogenesis of lymphocytic choriomeningitis in mice. II. The pathological histology. J Immunol (1961) 0.92
Antibody response to two different live poliomyelitis virus vaccines. N Y State J Med (1962) 0.85
PROTECTION AGAINST THE LETHAL EFFECT OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN MICE BY NEONATAL THYMECTOMY. Nature (1964) 0.82
Growth characteristics of hemadsorption virus type 1 (myxovirus parainfluenza 3) in tissue culture. Virology (1961) 0.81